Skip to main content
Top

Open Access 20-11-2023 | Multiple Sclerosis | COMMENTARY

Podcast on Identifying and Understanding Barriers to Care in Underserved Populations With MS in the United States

Authors: Sandra Parawira, Victoria Reese

Published in: Neurology and Therapy

Login to get access

Abstract

Multiple sclerosis (MS) can affect people from all racial and ethnic backgrounds, but, historically, the incidence of MS in the United States was thought to be highest in White individuals. More recent data suggest that the incidence of MS in Black or African American individuals is comparable to that in White individuals. In Hispanic or Latino individuals, incidence of MS is lower, but age of onset may be earlier compared with White individuals. Additionally, there are important differences in MS disease severity, disease progression, and mortality in Black or African American and Hispanic or Latino populations. Compared with their White counterparts, individuals from these underrepresented groups are more likely to be affected by MS in specific areas of the nervous system, such as accelerated loss of retinal and brain tissue in Black or African American individuals and optic neuritis in Hispanic individuals. Additionally, Black or African American individuals with MS tend to have an aggressive disease course, earlier disability, and higher risk of requiring ambulatory assistance. Although these differences may be attributed to genetic factors, systemic racism and biases and barriers to accessing care may perpetuate health disparities. Moreover, non-White communities remain broadly underrepresented in clinical trials; however, it is vital that these populations are appropriately represented so that any potential differences in drug efficacy or safety implications are detected. Thus, it is important to increase awareness of MS in these populations. In this podcast, the authors discuss characteristics of MS in Black or African American and Hispanic or Latino populations, identify barriers to care, and propose solutions to improve access to MS care in these populations.
MP4 (358385 KB)
Literature
1.
go back to reference Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26:1816–21. CrossRefPubMedPubMedCentral Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26:1816–21. CrossRefPubMedPubMedCentral
2.
go back to reference Cree BAC, Khan O, Bourdette D, et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 2004;63:2039–45. CrossRefPubMed Cree BAC, Khan O, Bourdette D, et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 2004;63:2039–45. CrossRefPubMed
3.
go back to reference Romanelli RJ, Huang Q, Lacy J, Hashemi L, Wong A, Smith A. Multiple sclerosis in a multi-ethnic population from Northern California: a retrospective analysis, 2010–2016. BMC Neurol. 2020;20:163. CrossRefPubMedPubMedCentral Romanelli RJ, Huang Q, Lacy J, Hashemi L, Wong A, Smith A. Multiple sclerosis in a multi-ethnic population from Northern California: a retrospective analysis, 2010–2016. BMC Neurol. 2020;20:163. CrossRefPubMedPubMedCentral
4.
go back to reference Langer-Gould AM, Gonzales EG, Smith JB, Li BH, Nelson LM. Racial and ethnic disparities in multiple sclerosis prevalence. Neurology. 2022;98:e1818–27. CrossRefPubMedPubMedCentral Langer-Gould AM, Gonzales EG, Smith JB, Li BH, Nelson LM. Racial and ethnic disparities in multiple sclerosis prevalence. Neurology. 2022;98:e1818–27. CrossRefPubMedPubMedCentral
6.
go back to reference Pérez CA, Lincoln JA. Racial and ethnic disparities in treatment response and tolerability in multiple sclerosis: a comparative study. Mult Scler Relat Disord. 2021;56: 103248. CrossRefPubMed Pérez CA, Lincoln JA. Racial and ethnic disparities in treatment response and tolerability in multiple sclerosis: a comparative study. Mult Scler Relat Disord. 2021;56: 103248. CrossRefPubMed
7.
go back to reference Ventura RE, Antezana AO, Bacon T, Kister I. Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans. Mult Scler. 2017;23:1554–7. CrossRefPubMed Ventura RE, Antezana AO, Bacon T, Kister I. Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans. Mult Scler. 2017;23:1554–7. CrossRefPubMed
8.
go back to reference Kister I, Chamot E, Bacon JH, et al. Rapid disease course in African Americans with multiple sclerosis. Neurology. 2010;75:217–23. CrossRefPubMed Kister I, Chamot E, Bacon JH, et al. Rapid disease course in African Americans with multiple sclerosis. Neurology. 2010;75:217–23. CrossRefPubMed
9.
go back to reference Amezcua L, Rivas E, Joseph S, Zhang J, Liu L. Multiple sclerosis mortality by race/ethnicity, age, sex, and time period in the United States, 1999–2015. Neuroepidemiology. 2018;50:35–40. CrossRefPubMed Amezcua L, Rivas E, Joseph S, Zhang J, Liu L. Multiple sclerosis mortality by race/ethnicity, age, sex, and time period in the United States, 1999–2015. Neuroepidemiology. 2018;50:35–40. CrossRefPubMed
10.
go back to reference Naismith RT, Trinkaus K, Cross AH. Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review. Mult Scler. 2006;12:775–81. CrossRefPubMed Naismith RT, Trinkaus K, Cross AH. Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review. Mult Scler. 2006;12:775–81. CrossRefPubMed
11.
go back to reference Gonzalez Caldito N, Saidha S, Sotirchos ES, et al. Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study. Brain. 2018;141:3115–29. CrossRef Gonzalez Caldito N, Saidha S, Sotirchos ES, et al. Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study. Brain. 2018;141:3115–29. CrossRef
12.
go back to reference Amezcua L, Lerner A, Ledezma K, et al. Spinal cord lesions and disability in Hispanics with multiple sclerosis. J Neurol. 2013;260:2770–6. CrossRefPubMed Amezcua L, Lerner A, Ledezma K, et al. Spinal cord lesions and disability in Hispanics with multiple sclerosis. J Neurol. 2013;260:2770–6. CrossRefPubMed
13.
go back to reference Amezcua L, Beecham AH, Delgado SR, et al. Native ancestry is associated with optic neuritis and age of onset in Hispanics with multiple sclerosis. Ann Clin Transl Neurol. 2018;5:1362–71. CrossRefPubMedPubMedCentral Amezcua L, Beecham AH, Delgado SR, et al. Native ancestry is associated with optic neuritis and age of onset in Hispanics with multiple sclerosis. Ann Clin Transl Neurol. 2018;5:1362–71. CrossRefPubMedPubMedCentral
14.
go back to reference Amezcua L, Oksenberg JR, McCauley JL. MS in self-identified Hispanic/Latino individuals living in the US. Mult Scler J Exp Transl Clin. 2017;3:2055217317725103. PubMedCentral Amezcua L, Oksenberg JR, McCauley JL. MS in self-identified Hispanic/Latino individuals living in the US. Mult Scler J Exp Transl Clin. 2017;3:2055217317725103. PubMedCentral
16.
17.
go back to reference Klineova S, Nicholas J, Walker A. Response to disease modifying therapies in African Americans with multiple sclerosis. Ethn Dis. 2012;22:221–5. PubMed Klineova S, Nicholas J, Walker A. Response to disease modifying therapies in African Americans with multiple sclerosis. Ethn Dis. 2012;22:221–5. PubMed
18.
go back to reference Cree BAC, Al-Sabbagh A, Bennett R, Goodin D. Response to interferon beta-1a treatment in African American multiple sclerosis patients. Arch Neurol. 2005;62:1681–3. CrossRefPubMed Cree BAC, Al-Sabbagh A, Bennett R, Goodin D. Response to interferon beta-1a treatment in African American multiple sclerosis patients. Arch Neurol. 2005;62:1681–3. CrossRefPubMed
19.
go back to reference Saidenberg L, Arbini AA, Silverman GJ, Lotan I, Cutter G, Kister I. Faster B-cell repletion after anti-CD20 infusion in Black patients compared to white patients with neurologic diseases. Mult Scler Relat Disord. 2022;63: 103830. CrossRefPubMed Saidenberg L, Arbini AA, Silverman GJ, Lotan I, Cutter G, Kister I. Faster B-cell repletion after anti-CD20 infusion in Black patients compared to white patients with neurologic diseases. Mult Scler Relat Disord. 2022;63: 103830. CrossRefPubMed
20.
go back to reference Tardo L, Greenberg B, Horton L. Utilization of health resources and disease modifying therapy use in a high risk, underserved multiple sclerosis patient population and associated impact on disease progression and disability. Neurology. 2020;94:1950. Tardo L, Greenberg B, Horton L. Utilization of health resources and disease modifying therapy use in a high risk, underserved multiple sclerosis patient population and associated impact on disease progression and disability. Neurology. 2020;94:1950.
21.
go back to reference Shabas D, Heffner M. Multiple sclerosis management for low-income minorities. Mult Scler. 2005;11:635–40. CrossRefPubMed Shabas D, Heffner M. Multiple sclerosis management for low-income minorities. Mult Scler. 2005;11:635–40. CrossRefPubMed
22.
go back to reference Hacker K, Anies M, Folb BL, Zallman L. Barriers to health care for undocumented immigrants: a literature review. Risk Manag Healthc Policy. 2015;8:175–83. CrossRefPubMedPubMedCentral Hacker K, Anies M, Folb BL, Zallman L. Barriers to health care for undocumented immigrants: a literature review. Risk Manag Healthc Policy. 2015;8:175–83. CrossRefPubMedPubMedCentral
24.
go back to reference Onuorah HM, Charron O, Meltzer E, et al. Enrollment of non-White participants and reporting of race and ethnicity in phase III trials of multiple sclerosis DMTs: a systematic review. Neurology. 2022;98:e880–92. CrossRefPubMed Onuorah HM, Charron O, Meltzer E, et al. Enrollment of non-White participants and reporting of race and ethnicity in phase III trials of multiple sclerosis DMTs: a systematic review. Neurology. 2022;98:e880–92. CrossRefPubMed
25.
go back to reference Hamilton RH, Ciccarelli O. Non-White participants matter in white matter disease studies: the importance of diversity in multiple sclerosis clinical trials. Neurology. 2022;98:345–6. CrossRefPubMed Hamilton RH, Ciccarelli O. Non-White participants matter in white matter disease studies: the importance of diversity in multiple sclerosis clinical trials. Neurology. 2022;98:345–6. CrossRefPubMed
26.
go back to reference Pimentel Maldonado DA, Moreno A, Williams MJ, et al. Perceptions and preferences regarding multiple sclerosis research among racial and ethnic groups. Int J MS Care. 2021;23:170–7. CrossRefPubMed Pimentel Maldonado DA, Moreno A, Williams MJ, et al. Perceptions and preferences regarding multiple sclerosis research among racial and ethnic groups. Int J MS Care. 2021;23:170–7. CrossRefPubMed
27.
go back to reference Corneli A, Hanlen-Rosado E, McKenna K, et al. Enhancing diversity and inclusion in clinical trials. Clin Pharmacol Ther. 2023;113:489–99. CrossRefPubMed Corneli A, Hanlen-Rosado E, McKenna K, et al. Enhancing diversity and inclusion in clinical trials. Clin Pharmacol Ther. 2023;113:489–99. CrossRefPubMed
28.
go back to reference Daverio-Zanetti S, Schultz K, del Campo MA, Malcarne V, Riley N, Sadler GR. Is religiosity related to attitudes toward clinical trials participation? J Cancer Educ. 2015;30:220–4. CrossRefPubMedPubMedCentral Daverio-Zanetti S, Schultz K, del Campo MA, Malcarne V, Riley N, Sadler GR. Is religiosity related to attitudes toward clinical trials participation? J Cancer Educ. 2015;30:220–4. CrossRefPubMedPubMedCentral
30.
go back to reference Okai AF, Howard AM, Williams MJ, et al. Advancing care and outcomes for African American patients with multiple sclerosis. Neurology. 2022;98:1015–20. CrossRefPubMedPubMedCentral Okai AF, Howard AM, Williams MJ, et al. Advancing care and outcomes for African American patients with multiple sclerosis. Neurology. 2022;98:1015–20. CrossRefPubMedPubMedCentral
31.
go back to reference Chiong-Rivero H, Robers M, Martinez A, et al. Effectiveness of film as a health communication tool to improve perceptions and attitudes in multiple sclerosis. Mult Scler J Exp Transl Clin. 2021;7:2055217321995947. PubMedPubMedCentral Chiong-Rivero H, Robers M, Martinez A, et al. Effectiveness of film as a health communication tool to improve perceptions and attitudes in multiple sclerosis. Mult Scler J Exp Transl Clin. 2021;7:2055217321995947. PubMedPubMedCentral
Metadata
Title
Podcast on Identifying and Understanding Barriers to Care in Underserved Populations With MS in the United States
Authors
Sandra Parawira
Victoria Reese
Publication date
20-11-2023
Publisher
Springer Healthcare
Published in
Neurology and Therapy
Print ISSN: 2193-8253
Electronic ISSN: 2193-6536
DOI
https://doi.org/10.1007/s40120-023-00559-5